Skip to main content

Table 2 Trial oversight committees

From: The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial

Name

Affiliation

Role and responsibilities

Trial Management Group

Professor Andrew Wilson

University of East Anglia

Chief investigator

Matthew Hammond

Norwich Clinical Trials Unit

Clinical trial manager

Dr. Allan Clark

University of East Anglia

Statistician

Martin Pond

Norwich Clinical Trials Unit

Head of data management

Dr. Tony Cahn

Bedford Hospitals NHS Trust

Co-investigator

Dr. Helen Parfrey

Papworth Hospital NHS Foundation Trust

Co-investigator

Dr. David Thickett

University of Birmingham

Co-investigator

Professor Moira Whyte

University of Edinburgh

Co-investigator

Dr. Toby Maher

Royal Brompton and Harefield NHS Foundation Trust

Co-investigator

Professor Bill Fraser

University of East Anglia

Co-investigator

Professor David Livermore

University of East Anglia

Co-investigator

Professor Ann Marie Swart

Norwich Clinical Trials Unit

Co-investigator

In addition a patient representative will be invited to attend Trial Management Group meetings

Independent Trial Steering Committee

Professor Ron du Bois

Imperial College

Independent chair

Dr. Nicholas Harrison

University of Swansea

Independent member

Professor Ann Millar

University of Bristol

Independent member

Dr. Sanjay Agrawal

University Hospitals Leicester NHS Trust

Non-independent member

In addition a patient representative will be invited to attend committee meetings

Independent Data Monitoring Committee

Dr. Nik Hirani

University of Edinburgh

Chair

Dr. Jack Bowden

University of Bristol

Statistician

Dr. Sarah Pett

MRC Clinical Trials Unit, UCL

Member